Cite

    Kang, D., Ludwig, E., Jaworowicz, D., Huang, H., Fiedler‐Kelly, J., Cortes, J., Ganguly, S., Khaled, S., Krämer, A., Levis, M., Martinelli, G., Perl, A., Russell, N., Abutarif, M., Choi, Y., Mendell, J., & Yin, O. (2020). population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia. Journal of clinical pharmacology, 60, 1629–1641. http://access.bl.uk/ark:/81055/vdc_100113737495.0x000050